Skip to content
  • Register
  • Log in
  • Facebook icon
  • LinkedIn icon
  • Instagram icon
  • YouTube icon
OptiScan | Endomicroscopic imaging technologies for medical, translational and pre-clinical markets

OptiScan

    OptiScan | Endomicroscopic imaging technologies for medical, translational and pre-clinical markets
  • Products
    • FIVE2
    • Customisation options
  • Applications
    • Gallery
    • Publications
    • Application Notes
    • Presentations
  • Technology
  • About
    • Company
    • Customers
    • Partners
    • Distributors
    • Quality and Certification
    • Optiscan Board
    • OptiScan Team
    • Joint Venture Opportunities
  • Service & support
    • FAQs
    • User Manual
    • Tutorials
    • Contact Support
  • Investors & media
    • ASX Announcements
    • News
    • Investor Presentations
    • Annual Reports
    • Corporate Governance
  • Contact us
  • Investors & media
  • News

News category Announcements

  • 14 January, 2021

    Optiscan secures further orders from Carl Zeiss

    Announcements
  • 12 January, 2021

    Two new clinical publications for CONVIVO in brain cancer

  • 18 December, 2020

    Optiscan’s Melbourne Dental School Study Featured in Melbourne’s Herald Sun

  • 17 December, 2020

    Melbourne Dental School and Optiscan’s Oral Cancer Screening Study discussed in Bite magazine – leading business magazine for dental professionals

  • OptiScan
    16 December, 2020

    Appointment of J&H Technology Co Ltd as Optiscan’s exclusive pre-clinical distributor for Taiwan

  • 3 December, 2020

    Melbourne Dental School and Optiscan Present at The 2nd China Smart Health and Medical Conference 2020

  • 26 November, 2020

    AGM 2020 Presentation

  • 17 November, 2020

    New publication on live cervical cancer imaging using OptiScan’s FIVE2 device

  • 10 November, 2020

    Therapeutic Goods Administration (TGA) Approval for CONVIVO® and Sterile Sheath in Australia

    Announcements
  • 12 October, 2020

    OptiScan’s Oral Cancer Screening Study with the Melbourne Dental School published in the Victorian Dentist Magazine by the Australian Dental Association

  • 9 October, 2020

    United States Food and Drug Administration (FDA) Regulatory Approval Update

    Announcements
  • OptiScan
    24 September, 2020

    Optiscan Capital Raising

    Announcements
  • 1
  • 2
  • Next

News categories

  • Announcements
  • Uncategorized

Secondary navigation

In the Investors & media section

  • ASX Announcements
  • News
  • Annual Reports
  • Corporate Governance
  • Investor Presentations

FIVE2 (ViewnVivo):
Exceptional in vivo imaging

Find out more

Keep up to date with OptiScan news

  • This field is for validation purposes and should be left unchanged.
OptiScan
  • +61 (3) 9538 3333
  • info@optiscan.com
  • Products
    • FIVE2
    • Customisation options
  • Applications
    • Gallery
    • Publications
    • Application Notes
    • Presentations
  • Technology
  • About
    • Company
    • Customers
    • Partners
    • Distributors
    • Quality and Certification
    • Optiscan Board
    • OptiScan Team
    • Joint Venture Opportunities
  • Service & support
    • FAQs
    • User Manual
    • Tutorials
    • Contact Support
  • Investors & media
    • ASX Announcements
    • News
    • Investor Presentations
    • Annual Reports
    • Corporate Governance
  • Contact us
DQS MED

© 2018 OptiScan  |  Privacy Policy

What are you looking for?